Tag: MHRA

Investigating Disintegration Failure in Multi-Strength Campaigns: Effective Sampling Plan Fixes to Prevent Repeat OOS Events In the realm of pharmaceutical manufacturing, the integrity of dosage forms is paramount. Disintegration failure…

Root Cause Analysis of Tablet Capping Issues for FDA Inspection Readiness Tablet capping is a significant concern for pharmaceutical manufacturers, particularly during FDA inspections. If left unaddressed, these issues can…

Addressing Blend Segregation Challenges Following Scale-Up: Parameters and Validation Considerations Blend segregation can pose significant challenges during the scale-up of solid oral dosage forms in pharmaceutical manufacturing. The potential for…

GMP Investigation Steps for Content Uniformity OOS Following Stability Pull In pharmaceutical manufacturing, ensuring content uniformity is critical for both product quality and compliance. A post-stability pull that reveals an…

Addressing Capsule Fill Weight Variation for FDA Inspection Readiness: Troubleshooting Tooling, Granulation, and Lubrication In the pharmaceutical manufacturing landscape, variations in capsule fill weight can prompt significant regulatory scrutiny, particularly…

Steps to Investigate Blend Segregation Following an Excipient Change in Pharmaceuticals In pharmaceutical manufacturing, the integrity of blended materials is crucial for ensuring product quality. Blend segregation following an excipient…

Guidelines for Tablet Lamination Processes to Ensure FDA Inspection Readiness In the pharmaceutical industry, the lamination of tablets is a critical process that can significantly impact product quality and compliance.…

Addressing Hardness Drift Following Excipient Changes: A Comprehensive Investigative Approach In pharmaceutical manufacturing, the integrity and quality of solid oral dosage forms, particularly tablets and capsules, are paramount. A common…

Documenting and Investigating Blend Segregation Following an Excipient Change in Pharmaceutical Manufacturing Blend segregation can significantly impact the quality of solid oral dosage forms, especially following an excipient change. In…

Investigation Steps for Tablet Capping Issues during High-Speed Runs Tablet capping during high-speed runs can present significant challenges in pharmaceutical manufacturing, leading to product quality issues and potential regulatory scrutiny.…

Addressing Capsule Fill Weight Variation for Optimal FDA Inspection Readiness Variation in capsule fill weight is a crucial quality concern that can lead to Out of Specification (OOS) results and…

Addressing Content Uniformity OOS Issues for FDA Inspection Readiness: A Step-by-Step GMP Investigation Guide Content uniformity is a critical parameter in pharmaceutical manufacturing, particularly for solid oral dosage forms such…